[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346416-105":59,"doc-detail-346416-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","harmine-derivatives-as-anticancer-agents-endowed-with-potent-and-selective-antileukemia-activity-synthesis-biological-evaluation-proapoptotic-and-genotoxic-activity","Harmine Derivatives as Anticancer Agents Endowed With Potent and Selective Antileukemia Activity - Synthesis, Biological Evaluation, Proapoptotic and Genotoxic Activity","","β-Carboline alkaloids such as harmine (1) are studied as anticancer candidates. The work evaluates the antiproliferative activity of compound 1 and thirty-three N9-substituted harmine derivatives across multiple cancer cell lines. Derivative 6, an aharmine analog with a 3,5-dimethylbenzyl substituent, shows the strongest potency and cancer-cell selectivity. IC50 values fall below 10 µM in tested cancer lines, while non-cancerous cells exceed 100 µM. Growth inhibition is confirmed by viability assays and real-time xCELLigence monitoring, with G1 arrest in MOLT-4 and apoptosis evidenced by Annexin V/PI, TUNEL, and caspase activation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/harmine-derivatives-as-anticancer-agents-endowed-with-potent-and-selective-antileukemia-activity-synthesis-biological-evaluation-proapoptotic-and-genotoxic-activity/346416/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/harmine-derivatives-as-anticancer-agents-endowed-with-potent-and-selective-antileukemia-activity-synthesis-biological-evaluation-proapoptotic-and-genotoxic-activity/346416.png","ImageObject",300,407,{"name":92,"@type":93},"Anda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main goal of evaluating harmine and its N9-substituted derivatives?","Question",{"text":112,"@type":113},"To assess antiproliferative activity as anticancer candidates by comparing compound 1 and 33 N9-substituted derivatives across a panel of cancer cell lines.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which derivative showed the strongest anticancer performance and what were its key results?",{"text":117,"@type":113},"Derivative 6 was the most potent, with IC50 values below 10 µM in all tested cancer cell lines, while IC50 in non-cancerous cells exceeded 100 µM.",{"name":119,"@type":110,"acceptedAnswer":120},"How was cell-cycle arrest and apoptosis experimentally confirmed?",{"text":121,"@type":113},"Flow cytometry showed G1 phase arrest in MOLT-4 cells. Apoptosis was confirmed using Annexin V/PI staining, TUNEL assays, and caspase activation studies.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},346416,1790132776,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":41,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","Archiv der Pharmazie   \n FULL PAPER   \nHarmine Derivatives as Anticancer Agents Endowed With Potent and Selective Antileukemia Activity: Synthesis, Biological Evaluation, Proapoptotic and Genotoxic Activity  \nAbdul Aziz Timbilla1  | Filip Pidany2  | Eliska Kohelova2 | Jana Kroustkova2 | Karel Kralovec3 | Jan Rataj4  | Martina Ceckova4 | Negar Maafi2 | Víctor Lopez5 | Cristina Moliner Langa5  | Stefan Kosturko2,6 | Jaroslav Jenco2 | Darina Muthna1  | Darja Koutova1  | Martina Rezacova1  | Lucie Cahlikova2 | Jakub Chlebek2  |  \nRadim Havelek1   \n1Department of Medical Biochemistry, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic | 2Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Hradec Kralove, Czech Republic | 3Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Pardubice, Czech Republic | 4Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic | 5Faculty of Health Sciences, Universidad San Jorge, Zaragoza,  \nSpain | 6Department of Analytical Chemistry, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic Correspondence: Jakub Chlebek ([chlej2aa@faf.cuni.cz](chlej2aa@faf.cuni.cz)) | Radim Havelek ([havelekr@lfhk.cuni.cz](havelekr@lfhk.cuni.cz))  \nReceived: 26 August 2025 | Revised: 20 January 2026 | Accepted: 27 January 2026  \nFunding: Ministerstvo Školství, Mládeže a Tělovýchovy, Grant/Award Number: CZ.02.01.01/00/23_ 021/0008442; Univerzita Karlova v Praze, Grant/Award Numbers: Cooperatio Program, research area DIAG, SVV‐2025‐260776, SVV‐2025‐260774, SVV‐2025‐260782  \nKeywords: cancer | cell cycle | cytotoxicity | DNA damage | harmine | semisynthetic derivatives  \nABSTRACT  \nβ‐Carboline alkaloids, such as harmine (1), have demonstrated notable anticancer properties, making them attractive candidates for anticancer drug development. This study evaluated the antiproliferative activity of compound 1 and thirty‐three N9‐substituted derivatives across a panel of cancer cell lines representing various histotypes. Among these, derivative 6, aharmine analog bearing a 3,5‐dimethylbenzyl substituent, was the most potent, showing enhanced cytotoxicity and selectivity toward cancer cells. Compound 6 exhibited IC50 values below 10 µM in all tested cancer cell lines, while its IC50 in non‐ cancerous cells exceeded 100 µM. Viability assays and xCELLigence real‐time monitoring confirmed a concentration‐dependent inhibition of cancer cell growth with minimal effects on non‐malignant cells. Flow cytometry demonstrated G1 phase arrest in MOLT‐4 cells, supported by Western blot data showing reduced phosphorylated Rb and increased p27 protein levels. Apoptosis  \n\n| Abbreviations: AChE, acetylcholinesterase; ADME, absorption, distribution, metabolism, excretion; AKT, protein kinase B; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; Bax, Bcl‐2‐associated X protein; BBB, blood–brain barrier; Bcl‐2, B cell lymphoma 2; CDK, cyclin‐dependent kinase; CI, cell index; CNS, central nervous system; COX‐2, cyclooxygenase‐2; DAPI, 4′,6‐diamidino‐2‐phenylindole; DMF, dimethylformamide; DMSO, dimethyl sulfoxide; DNA, deoxyribonucleic acid; DNMTs, DNA methyltransferase; DPBS, Dulbecco's phosphate‐buffered saline; DSB, double‐strand break; DYRK1A, dual‐specificity tyrosine‐phosphorylation‐ regulated kinase 1A; EMT, epithelial–mesenchymal transition; ERK, extracellular signal‐regulated kinase; ESI‐HRMS, electrospray ionization high‐resolution mass spectrometry; ESOL, estimated solubility; FDA, Food and Drug Administration; FITC‐dUTP, fluorescein isothiocyanate‐labeled deoxyuridine; FLT3, FMS‐like tyrosine kinase 3; FLT3‐ITD, FLT3‐internal tandem duplication; GHS, globally harmonized system; GI, gastrointestinal; GP, growth percentage; GSK‐3β, glycogen synthase kinase‐ 3β; H2AX, H2A histone fa","cbCaidHPh3LBi0xJ","https://ap.wps.com/l/cbCaidHPh3LBi0xJ","pdf",4437288,"English","# Abstract\n## Biological evaluation across cancer cell lines\n## Selectivity and cytotoxic potency (IC50)\n## Cell cycle arrest and mechanistic signals\n## Apoptosis and genotoxic activity evidence","[{\"question\":\"What was the main goal of evaluating harmine and its N9-substituted derivatives?\",\"answer\":\"To assess antiproliferative activity as anticancer candidates by comparing compound 1 and 33 N9-substituted derivatives across a panel of cancer cell lines.\"},{\"question\":\"Which derivative showed the strongest anticancer performance and what were its key results?\",\"answer\":\"Derivative 6 was the most potent, with IC50 values below 10 µM in all tested cancer cell lines, while IC50 in non-cancerous cells exceeded 100 µM.\"},{\"question\":\"How was cell-cycle arrest and apoptosis experimentally confirmed?\",\"answer\":\"Flow cytometry showed G1 phase arrest in MOLT-4 cells. Apoptosis was confirmed using Annexin V/PI staining, TUNEL assays, and caspase activation studies.\"}]","Harmine Derivatives as Anticancer Agents Endowed With Potent and Selective Antileukemia Activity - Synthesis, Biological Evaluation, Proapoptotic and Genotoxic Activity | PDF",1790061355,76,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ddda14cc639457d8e5db79d0257ff5dc.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/98cb35c209b44786050d5c5d68c9d6c1.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de7caf45437db83e5f4051ebd0ba58cd.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/01f8f61acce54efc76173e676feeb973.webp",980,1287]